Hepatocyte Nuclear Factor 1 Inactivation Results in Hepatic Dysfunction, Phenylketonuria, and Renal Fanconi Syndrome  by Pontoglio, Marco et al.
Cell, Vol. 84, 575±585, February 23, 1996, Copyright 1996 by Cell Press
Hepatocyte Nuclear Factor 1 Inactivation
Results in Hepatic Dysfunction, Phenylketonuria,
and Renal Fanconi Syndrome
Marco Pontoglio,* Jacqueline Barra,² HNF1a and HNF1b, or LF-B1 and LF-B3) (Frain et al.,
1989; Chouard et al., 1990; Baumhueter et al., 1990; ReyMichelle Hadchouel,³ Antonia Doyen,* Chantal Kress,²
Campos et al., 1991; De Simone et al., 1991); HNF3a,JoseÂphine Poggi Bach,§ Charles Babinet,²
HNF3b, and HNF3g (Lai et al., 1990); HNF4 (Sladek etand Moshe Yaniv*
al., 1990); CCAAT enhancer±binding protein (C/EBPa,*UniteÂ des Virus OncogeÁ nes
C/EBPb, and C/EBPg) (Johnson et al., 1987; Cao et al.,UniteÂ de Recherche AssocieÂe 1644
1991); and rat albumin D element±binding protein (DBP)du Centre National de la Recherche Scientifique
(Mueller et al., 1990).DeÂ partement des Biotechnologies
HNF1-binding sitesare found in many hepatic promot-²UniteÂ de Biologie du DeÂveloppement
ers including those for the albumin, a1-antitrypsin, andUniteÂ de Recherche AssocieÂe 1960
a- and b-fibrinogen genes. In the albumin promotersdu Centre National de la Recherche Scientifique
from mouse, rat, human, and Xenopus, HNF1 binds toInstitut Pasteur
a site centered 25 nt upstream of the TATA box. This25, rue du Dr. Roux
proximal element, along with the TATA box, is both75724 Paris Cedex 15
necessary and sufficient to drive transcription in a tis-France
sue-specific manner in transfection assays and in vitroUniteÂ 347
transcription. The cloning of the HNF1 cDNA revealed³Institut National de la SanteÂ
similarity to the homeobox genes. A unique feature ofet de la Recherche MeÂdicale
the HNF1 protein is the presence of an insertion of 21§Laboratoire de Biochimie
amino acids between the second and third helices ofHoÃ pital du Kremlin-BiceÃ tre
the classical homeodomain. HNF1 is composed of three80, rue du GeÂ neÂ ral Leclerc
functional domains: an N terminal dimerization domain,94276 Le Kremlin-BiceÃ tre Cedex
a DNA-binding domain (homeobox-like), and a C-termi-France
nal transactivation domain. Dimerization is necessary
for interaction with DNA as deletion of the dimerization
domain prevents DNA binding.Summary
Among vertebrates, with the exception of fish, a
closely related gene named vHNF1 (or HNF1b or LF-B3)HNF1 is a transcriptional activator of many hepatic
has also been characterized. HNF1 and vHNF1 sharegenes including albumin, a1-antitrypsin, and a- and
a similar structure with 75% sequence identity in the
b-fibrinogen. It is related to the homeobox gene family
dimerization domain and 93% in the DNA-binding do-
and is predominantly expressed in liver and kidney.
main. Their C-terminal transactivation domains are moreMice lacking HNF1 fail to thrive and die around wean-
divergent (47%). The two proteins can form heterodim-ing after a progressive wasting syndrome with a
ers via their N-terminal dimerization domains. Both bind
marked liver enlargement. The transcription rate of
the same targets and can act as positive transcriptional
genes like albumin and a1-antitrypsin is reduced,
regulators; however, HNF1 is a generally more potent
while the gene coding for phenylalanine hydroxylase
activator than vHNF1. Another partner for HNF1, named
is totally silent, giving rise to phenylketonuria. Mutant DCoH (dimerization cofactor for HNF1), has also been
mice also suffer from severe Fanconi syndrome cloned (Mendel et al., 1991). DCoH can bind to the
caused by renal proximal tubular dysfunction. The re- N-terminal domains of both HNF1 and vHNF1 in both
sulting massive urinary glucose loss leads to energy homodimer and heterodimer configurations. DCoH
and water wasting. HNF1-deficient mice may provide binding results in stabilization of the dimer complex and
a model for human renal Fanconi syndrome. an increase of its transactivation capacity. Surprisingly,
DCoH protein is also involved in the enzymatic dehydra-
Introduction tion of pterin-4-a-carbinolamine to dihydrobiopterin, a
cofactor involved in the enzymatic hydroxylation of phe-
One of the most intriguing aspects of development is nylalanine and tryptophan (Citron et al., 1992).
how differential gene expression is accomplished in HNF1 is expressed in liver, kidney, intestine, pancreas,
many different cell types that share identical DNA con- and stomach. HNF1 and vHNF1 are both expressed in
tent. An important step in the control of this process is the polarized epithelia present in all of these organs
the selective transcriptional activation of gene subsets (Frain et al., 1989; Chouard et al., 1990; Baumhueter et
(Maniatis et al., 1987). This depends on the concerted al., 1990; Rey Campos et al., 1991; De Simone et al.,
action of a small number of tissue-restricted transcrip- 1991). The expression pattern of vHNF1 overlaps that
tion factors. Dissection of promoters and enhancers of of HNF1 with some exceptions. For example, vHNF1 is
genes that are expressed preferentially in hepatocytes low in the liver but abundant in kidney. During embryonic
resulted in the identification of several nuclear proteins development, vHNF1 is expressed earlier than HNF1.
that bind to these sequences. Most of these factors are vHNF1 transcripts appear upon induction of hepatic en-
expressed in a limited number of cell types. This set of doderm in the foregut, whereas HNF1 is activated later
transcription factors includes hepatocyte nuclear factor and only upon condensation of the hepatic parenchyma
(Blumenfeld et al., 1991; Ott et al., 1991; Cereghini et1 and variant HNF1 (HNF1 and vHNF1, also known as
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al., 1992). During kidney development, vHNF1 is tran- analysis with a b-galactosidase probe (data not shown).
These clones, SA45 (D3 line electroporated with pH1scriptionally activated in the swelling ureteric bud and
in the surrounding metanephric mesenchyme before the plasmid) and D68 (CK11 line electroporated with pH2
plasmid), successfully colonized the germline of severalactivation of HNF1, which only becomes detectable with
the differentiation of S-shape structures (Lazzaro et al., mice. Heterozygotes were phenotypically indistinguish-
able from their wild-type littermates.1992). Thus, vHNF1 may be involved in the onset of
differentiation of polarized epithelia. HNF1 might func-
tion in a secondary step, possibly connected with the HNF1 Expression Pattern in Heterozygotes
maintenance or establishment of a correct terminal dif- Embryonicor adult heterozygous animals were analyzed
ferentiation state. To understand the role played by to document more precisely at the cellular level the
HNF1, we undertook its inactivation in the mouse. expression pattern of b-galactosidase under control of
the endogenous HNF1 promoter. X-Gal staining re-
vealed expression in the liver, kidney, pancreas, stom-Results
ach, and intestine (Figure 1; data not shown). During
embryonic development liver primordium, intestine andGeneration of Mice Lacking HNF1
mesonephros showed a significant positive stainingTo inactivate the HNF1 gene, we used two different
starting at day 10.5 postcoitus (Figure 1A; data nothomologous recombination vectors based on a posi-
shown). Liver showed a rather uniform staining with ev-tive±negative selection strategy (Mansour et al., 1988).
ery hepatocyte expressing b-galactosidase (Figure 1B).These constructions delete the coding portion of the
Positive signals were also seen in the deeper part of thefirst exon and differ essentially in the extension of the
gastric pits in the glandular stomach (Figure 1C). In thedeletion affecting the first intron. In both cases, the pro-
kidney, the signal was mainly confined to the cortex.moter (3 kb) and the 59 untranslated portion of the first
The most intense expression was localized to the deeperexon were linked to a b-galactosidase cassette at the
part of the cortex just in close proximity to the medullaposition of the HNF1 translation start codon. This re-
(Figures 1D and 1E). Histological thin sections revealedporter gene contains a nuclear localization signal at its
that only proximal tubules were actively transcribing theN-terminus and is followed by the early polyadenylation
transgene, whereasglomerular structures were negativesignal from SV40. Positive selection was based on a
(Figure 1F). Parallel immunofluorescence staining re-neomycin resistance cassette under controlof the phos-
vealed that HNF1 and villin colocalized in the proximalphoglycerate kinase (PGK) promoter and polyadenyla-
tubules (data not shown). In the outer medulla, projec-tion signal. For the first plasmid (pH1), we linked the
tions of X-Gal stained tubules were often visible. Thesedistal part of the first intron downstream of the neomycin
structures were probably the distal portion of the proxi-cassette. The second plasmid (pH2) used a proximal
mal tubule pars recta. These staining data are in goodportion of this same intron. The homologous recombina-
agreement with the HNF1 mRNA expression patterntion event should result in the deletion/replacement of
(Blumenfeld et al., 1991).the coding portion of the first exon with the b-galactosi-
dase and neomycin cassettes. This deletion removes
the first 108 amino acids of HNF1, which includes the HNF1 Deficiency Does Not Affect
Embryonic Developmententire dimerization domain and part of the B domain of
the protein. This mutation should inactivate HNF1, since Intercrosses between heterozygotes produced progeny
with a slightly decreased percentage (20%) of homozy-the endogenous promoter in the mutated allele tran-
scribes the b-galactosidase cassette instead of the par- gotes. Since identical phenotypes were observed with
animals generated with both targeted cell lines, in thistially deleted HNF1 gene. Furthermore, even if a trun-
cated HNF1 mRNA were synthesized, the resulting study, we have pooled the results from both lines.
HNF12/2 newborn pups were slightly yellowish with noprotein would be inactive since deletions of the dimer-
ization domain prevent HNF1 from binding DNA. This obvious abnormalities.
To confirm that HNF1 protein was indeed absent instrategy avoids the production of a protein that could
have a negative trans-dominant effect. For counterse- these animals, we prepared nuclear extracts from the
different mice and scored for the presence of proteinlection, we used a thymidine kinase cassette driven by
the same PGK promoter. complexes by gel shift assays using a double-stranded
oligonucleotide containing a HNF1-binding site. Previ-Two different embryonic stem (ES) cell lines, D3
(Gossler et al., 1986) and CK11 (C. K., unpublished data), ous studies have shown that complexes of DNA with
HNF1 homodimers, HNF1±vHNF1 heterodimers, andwere used in three independent electroporations. Ho-
mologous recombinants were detected by Southern blot vHNF1 homodimers each display distinct gel migration
patterns (Rey Campos et al., 1991; De Simone et al.,hybridization of BamHI genomic DNA digestions. The
probe was located outside the region of homology be- 1991). vHNF1 homodimers migrate faster than HNF1
homodimers, whereas the mobility of heterodimers istween the targeting vector and the locus. The detected
fragment length should be 8.5 kb for the wild-type allele intermediate. In addition, liver and kidney contain differ-
ent concentrations of the two proteins. Liver nuclearand 11.0 kb for the targeted mutation. The analysis of
331 clones resulted in the identification of five indepen- extracts from normal animals contain essentially HNF1
homodimers with a trace of HNF1±vHNF1 heterodimers.dent homologous recombinants. Two of them did not
contain any additional random insertion of the homolo- The latter species is usually poorly separated from HNF1
homodimer complexes, which form the predominantgous recombination vector as judged by Southern blot
Liver and Kidney Dysfunction in HNF1 Mutant Mice
577
Figure 1. b-Galactosidase Activity under the Transcriptional Control of the Endogenous HNF1 Promoter in Heterozygous Animals: Detection
with X-Gal Staining
(A) In toto X-Gal staining of a developing embryo at 11.5 days postcoitus. Liver (L), intestine (i), mesonephros (m). Scale bar, 100 mm.
(B) Thin section of adult liver (portal space): b-galactosidase activity is detectable in every hepatocyte. Bile duct (bd), hepatic artery (a), portal
vein (pv). Scale bar, 20 mm.
(C) Thin section of adult stomach: the arrow shows a gastric gland (g) with few scattered positively stained cells. Scale bar, 20 mm.
(D) In toto X-Gal staining of kidney section. Positive staining is mainly concentrated in the deep cortex. Cortex (c), medulla (m). Scale bar,
0.5 mm.
(E) Higher magnification of kidney section: tubular structures are clearly stained. Scale bar, 100 mm.
(F) Kidney thin section: positive signals are found in tubules but not in renal corpuscles. Renal corpuscle (rc). Scale bar, 20 mm. Proximal
tubular cells presented a nonuniform expression of the b-galactosidase.
band. Kidney extracts normally contain HNF1±vHNF1 the total HNF1 activity observed in wild-type animals
(phosphorimager quantitation). In nuclear extracts fromheterodimers and vHNF1 homodimers. Hepatic and re-
nal nuclear extracts from mutant homozygotes were mutant homozygote kidneys, only a binding activity mi-
grating at the position of vHNF1 homodimers was de-HNF1 free as judged by the band shift assays (Figure
2A). Only a weaker and faster migrating band in the tected, whereas in wild-type extracts bands corre-
sponding to vHNF1 homodimers and HNF1±vHNF1position corresponding to the vHNF1 homodimer±
binding activity was detected in HNF12/2 hepatic nuclear heterodimers were observed. The formation of the liver
and kidney complexes detected in mutant animals wereextracts. This residual vHNF1 activity was 10%±15% of
Cell
578
Figure 2. Analysis of the Expression of HNF1 and vHNF1
(A) Gel shift assay with nuclear extracts and a HNF1-binding site
probe from the b-fibrinogen pomoter. The same probe is recognized
by HNF1 homodimers, HNF1±vHNF1 heterodimers, and vHNF1 ho- Figure 3. Growth Curve of the Different Genotypes and Survival
modimers, and the position of each complex is arrowed. Liver (L) Rate
or kidney (K) nuclear exctracts. Rat anti-vHNF1 polyclonal antibody
(A) The curves show a typical ponderal growth course of a litter(GST±HNF1b) added to the last two lanes prevented residual com-
composed of four pups. Growth retardation is frequently detectedplex formation. Beneath is shown that similar amount of the ubiqui-
starting from the first or the second week of life. In this particulartous factor NFY or HNF4 liver-enriched factor was present in the
case, the homozygote died at day 36.extracts.
(B) Viability of 50 HNF1-deficient mice. The sharp decrease around(B) Western blots with hepatic and renal nuclear extracts. The posi-
day 25 overlaps the weaning period. Among more than 1000 homo-tion of HNF1 and vHNF1 proteins is indicated by arrows to the left.
zygotes, less than 1% lived longer than 3 months. No lethality isAdditional bands are due to nonspecific cross-reactivity, since they
observed in the controls (data not shown).are not detected with independently produced sera. HNF1 protein
was detected with a rabbit polyclonal antibody (TC284), whereas
vHNF1 was detected with a monoclonal antibody (3±12).
50% survived to day 26, less than 15% until day 42, and
less than 1% lived longer than 3 months. Viability sharply
decreased around day 25, immediately following theprevented by the addition of anti-vHNF1 polyclonal anti-
weaning period (Figure 3B). By postnatal day 20, mutantbodies. To control for the quality of the nuclear extracts,
homozygotes presented with muscular atrophy and losswe performed a band shift with a probe containing the
of subcutaneous fat. X-ray inspection revealed massiveubiquitous NFY CCAAT-binding element from the albu-
bone demineralization (data not shown). The few surviv-min promoter and with the HNF4-binding site from the
ing weaned homozygotes were polyphagic: their foodHNF1 promoter. These probesdetected similar amounts
intake was 30% higher per body weight unit. Weanedof NFY- and HNF4-binding activities between wild-type
mutants could not stand overnight fasting: the nextand homozygotes extracts (Figure 2A). As vHNF1 is only
morning they were very weak and eventually died.a minor constituent in liver, its presence was masked
Starting during their second week of life, mutant ho-in gel shifts using normal extracts by the large excess
mozygotes showed drastic liver enlargement. The liverof HNF1. To test whether the levels of vHNF1 protein
to body weight ratio reached 10% and was on averagewere increased in the livers of HNF12/2 mice, we per-
twice that of heterozygotes and wild-type controls. His-formed Western blotting. A monoclonal antibody spe-
tological analysis revealed that in 20% of the animalscific for vHNF1 revealed an increase in the concentration
this liver enlargement was accompanied by steatosis.of this protein in mutant livers (Figure 2B). By contrast,
Also, in 20% of the weaned homozygotes, we observedno increase was visible in kidney, where this protein is
some disorganization of the gastric glandular epitheliumvery abundant.
with a reduced thickness and a less compact structure.
Intestine, pancreas, and kidney showed no overt patho-Homozygous Mutants Fail to Thrive
logical sign either macroscopically or at the histologicalHomozygotes showed a reduced growth rate already
level.after the first week of life (see Figure 3A for an example).
After weaning, the body weight of HNF12/2 mice was on
average only 60% that of wild-type and ranged between Evidence for Liver Functional Defects
Hepatomegaly suggested that some of the liver func-40% and 80% of normal littermates. Homozygotes
started suffering from a progressive wasting syndrome tions might besuboptimal. As shown in Table 1, homozy-
gous animals had higher plasma transaminases andand cachexia around the end of the second week of life.
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Table 1. Plasma Biochemical Findings
HNF12/2 Controls Ratio n
Phenylalanine (mM) 1368.2 6 946.8 52.5 6 18.6 26.1 6a
Arginine (mM) 23.2 6 31.4 84.0 6 36.2 0.3 6b
Citrulline (mM) 142.5 6 48.4 63.3 6 19.6 2.3 6b
Lysine (mM) 220.3 6 93.6 346.8 6 134.8 0.6 6b
Hydroxyproline (mM) 266.5 6 216.0 21.8 6 11.5 12.2 6a
Tyrosine (mM) 76.5 6 19.4 51.5 6 19.6 1.5 6
Methionine (mM) 51.5 6 15.7 39.3 6 8.5 1.3 6
Uric acid (mM) 24.6 6 7.0 45.0 6 13.8 0.5 7b
Cholesterol (mM) 4.2 6 2.9 1.5 6 0.6 2.8 10b
Triglycerides (mM) 0.7 6 0.3 0.7 6 0.3 1.0 10
Glucose (mM) 13.1 6 4.7 10.4 6 1.5 1.3 10
Alkaline phosphatase (U/l) 476.7 6 383.4 183.2 6 70.1 2.6 6
AST (U/l) 260.5 6 175.6 77.7 6 21.1 3.4 6a
ALT (U/l) 163.0 6 136.4 28.4 6 14.6 5.7 6a
Concentration of plasma components for homozygotes and their littermate controls (eitherheterozygotes or wild type). No significant differences
were detected between wild type and heterozygotes. The ratios between mean values for homozygotes and the controls are indicated as are
the number of pairs analyzed for each point. Since homozygotes could not tolerate fasting, we analyzed the plasma of nonstarving animals.
For evaluating the statistical significance of the differences observed, we applied the student's t test for pairwise samples. The significance
is depicted with footnotes in the last column. AST stands for aspartate aminotransferase, ALT stands for alanine aminotransferase.
a P (T < t) , 0.05
b P (T < t) , 0.01
cholesterol levels. Mild hyperbilirubinemia (3- to 10-fold amino acids and metabolites (e.g., uric acid and phos-
phate) were also lost in the urine of the mutant animalsincrease versus normal) and mild hyperammonemia
(1.5- to 2-fold increase) sometimes associated with (Table 2). In the case of arginine, 65% of the glomerular
filtered plasmaamino acid was not reabsorbed, whereasorotic aciduria have also been found.Plasma-free amino
acid composition revealed that HNF12/2 animals had in the control this loss was only 0.4%. Many other amino
acids had a renal fractional excretion much higher thanvery high hydroxyproline levels and that they suffered
from a severe hyperphenylalaninemia with levels com- the controls (Table 2). The urinary calcium/creatinine
ratio was on average six times higher in the mutants.parable to the condition that in human is described as
phenylketonuria (PKU) (Scriver et al., 1989). Levels of Finally, the glomerular filtration rate, calculated on the
basis of the renal creatinine clearance normalized perarginine, uric acid, and lysine in homozygotes were sig-
nificantly lower than controls, while postprandial glyce- body weight, was on average 3-fold reduced in mutant
animals.mia was normal. Surprisingly, albumin and total plasma
protein content were not significantly different from the Renal glucose reabsorption is accomplished mainly
in the proximal tubule of the nephrons by a secondarycontrols.
active transport that uses the electrochemical gradient
Renal Dysfunction
Homozygotes showed the typical traits of the human Table 2. Renal Fractional Excretion Ratios
renal Fanconi syndrome characterized by polyuria, glu-
Fractional Excretion Ratios (Homozygotes/Controls)cosuria, aminoaciduria, phosphaturia, and bone demin-
eralization. Their diuresis was 2.6±15 times the control Glucose 878.8 Methionine 9.5
Citrulline 256.6 Ornithine 9.4levels and in some cases attained 85% of the body
Arginine 180.9 Glutammic acid 9.2weight in 24 hr. Half of the homozygotes had a daily
Hydroxyproline 51.2 Tyrosine 8.6diuresis of more than 40% of their body weight. Their
Histidine 48.7 Serine 6.7
urine was characterized by a very high glucose concen- Lysine 23.7 Alanine 6.5
tration (ranging between 240 and 1400 mM). Daily glu- Proline 22.4 Threonine 6.2
cose loss was on the average 600 mg and ranged be- Isoleucine 15.3 Ethanolamine 6.0
Glutamine 15.2 Aspartic acid 2.4tween 0.16 and 1.30 g for animals that had an average
Cysteine 12.8 Taurine 2.3weight of 8 g. As expected, polyuria showed a positive
Leucine 12.3 Glycine 2.3and significant correlation with the urinary glucose loss
Valine 12.3 Asparagine 2.0
(data not shown). These defects had an early onset: Phosphate 11.8 Phenylalanine 1.1
glucosuria was easily detected in homozygous pups
Ratios of renal fractional excretion of plasma constituents of homo-starting at 2 to 5 days of age. This glucosuria, which
zygotes and their heterozygous and wild-type littermate controls.
occurred in normoglycemic conditions, prompted us to Fractional excretion is relative to the creatinine clearance. These
test whether the mutants showed an abnormal glucose ratios give an idea of the relative homozygous renal ``leakage'' in
tolerance test. Intravenous glucose bolus showed that the proximal tubular reabsorption process for each constituent ana-
lyzed. For example, glucose in the homozygotes leaked 878 timeshomozygotes could recover normal glycemia levels with
more than the controls with respect to the total amount of glucosethe same kinetics as the littermate controls (data not
that was filtered in the glomeruli. The values are a mean of twoshown). The dysfunction in the reabsorption process
determinations.
was not restricted to glucose. Arginine as well as other
Cell
580
Figure 4. Phlorizin Binding to Kidney Brush Border Membrane Ves-
icles
Scatchard plot analysis of the binding of [3H]phlorizin to kidney
brush border membrane vesicles. The insert shows a plot of the
binding activity as a function of [3H] phlorizin concentration. Error
bars represent the standard error of five independent measure-
ments.
of Na1 across the luminal brush border membrane of
the tubular cells. This transport is mediated by a multi-
molecular complex that can be bound and inhibited
by the phlorizin glucoside, a competitive inhibitor of
this transport machinery (Brenner and Rector, 1991).
Scatchard plot analysis of the binding of this glucoside
Figure 5. Expression of Hepatic Genesto brush border vesicles prepared from homozygous or
Northern blot analysis on total RNA or poly(A)1 mRNA from animalswild-type kidneys showed that there was in fact a 2-fold
of 12±15 days of age. Three samples for each genotype are shown.
decrease in the number of active binding sites per milli- Mean values and standard errors of the signals quantified by phos-
gram of protein relative to the control (Figure 4). phorimager are represented on the right. vHNF1 histograms repre-
sent the average from a total of six animals for each genotype.
Homozygotes PAH signals were undetectable even with much
Transcription of HNF1 Target Genes longer exposures. Albumin (Alb); a1 antitrypsin (a1 AT), b-fibrinogen
As mentioned above, we were surprised to find normal (b Fib); phosphoenolpyruvate carboxy-kinase (PEPCK); protein C
(ProC); dimerization cofactor for HNF1 (DCoH); phenylalanine hy-amounts of albumin protein in the serum of HNF1-defi-
droxylase (PAH); ethydium bromide (RNA) stained denaturing aga-cient animals. To clarify this issue further, we analyzed
rose gels showing similar amount of total RNA in each lane. Alb, a1by Northern blotting the steady-state levels of a number
AT, b Fib, PEPCK, ProC, and DCoH have been detected on 15 mg
of hepatic mRNA species including the following: total RNA, whereas PAH, HNF1, vHNF1, HNF4, and b-actin were
albumin, a1-antitrypsin, b-fibrinogen, pyruvate kinase, detected on 3 mg of poly(A)1 mRNA.
tyrosine amminotransferase, aldolase B, glutathione
S-transferase (GST), fructose diphosphatase, trans-
thyretine, a-fetoprotein, protein C, phenylalanine hy- message in homozygous liver (Figure 5). We also exam-
ined the levels of the mRNA encoding DCoH and founddroxylase, and phosphoenolpyruvate carboxy-kinase
(PEPCK) (Figure 5; data not shown). Most of these genes that it was consistantly lower in the mutant animals
compared to the controls. As expected, the canonicalhave an HNF1-bindingsite in their transcriptional control
sequences. In young animals (12 days), albumin and a1- HNF1 messenger was not detected in the mutant mice.
Only two very faint and aberrantly sized bands wereantitrypsin steady-state levels were reduced to 50% and
30% of the wild-type or heterozygotes levels. However, detected in the HNF12/2 mice. This mRNA species did
not give rise to any immunologically detectable HNF1in the small percentage of mutant animals surviving the
weaning period in a healthy condition, both albumin and protein as Western blot analysis failed to reveal any
residual signal in either kidney or liver extracts froma1-antitrypsin mRNAs accumulated to almost normal
levels (data not shown). The elevated phenylalanine homozygous mutant mice (Figure 2B). vHNF1 mRNA
was up-regulated about 2-fold, whereas HNF4 mRNAplasma levels prompted us to investigate if the mRNA
encoding for phenylalanine hydroxylase (PAH; the en- levels were not significantly different between wild type
and homozygotes (Figure 5). For some genes (e.g.,zyme responsible for the catabolic degradation of phe-
nylalanine) was properlyexpressed. Northern blot analy- PEPCK), we observed a large range of expression. This
might be related to the differing nutritional status ofsis on poly(A)1 mRNA failed to detect any trace of PAH
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the animals. In fact, as homozygotes were intolerant to Liver Phenotype
Homozygous mutants suffered from a severe hyperphe-overnight starvation, we could not analyze mRNA levels
in fasted animals. nylalaninemia. This condition was caused by lack of
transcription of the PAH gene, which is expressed pre-It was surprising that albumin mRNA, the paradigm
of a gene controlled by HNF1, was only reduced by dominantly in the liver. This gene is controlled by func-
tional HNF1-binding sites present in one of its enhancers2-fold in young mutant mice. To determine whether the
transcription rate of the albumin gene was altered in the (D. Faust and M. Weiss, personal communication). It is
unclear at present why the lackof HNF1 totally abolishedmutant mice, we performed nuclear run-onexperiments.
Six independent experiments showed that the transcrip- its transcription while other target genes like albumin
were only partially affected. Perhaps vHNF1 can substi-tion rate for the albumin gene was reduced to 25%±30%
of the controls. Run-on analysis also revealed that tran- tute for HNF1 activity in promoters but not in enhancers.
Alternatively, the relatively weak HNF1 sites in the PAHscription of b-fibrinogen was not affected and a1-anti-
trypsin was reduced 2-fold while nascent transcripts enhancer are unable to compete for limiting vHNF1 in
the presence of the high affinity sites in many otheroriginating from the phenylalanine hydroxylase gene
were undetectable (data not shown). genes. Thus, genes containing essential weak affinity
sites might be particularly affected.
Phenylalanine hydroxylation is an obligatory step forDiscussion
the metabolic conversion of this essential amino acid.
Phenylalanine can either be oxidized to CO2 and waterWe show here that HNF1-deficient mice were born with
almost normal frequency and that they did not present or converted through the gluconeogenic pathway to glu-
cose. If the PAH enzyme is inactive, phenylalanine can-any gross hepatic and renal structural defects at birth.
Furthermore, mRNA for many HNF1 hepatic target genes not be cleared from the plasma and its accumulation
results in PKU. Affected patients, if not treated with awas still present, although some had reduced levels.
The persistent transcription of known HNF1 targets in phenylalanine-restricted diet, suffer from mental retar-
dation, seizure, and impaired growth and eventually diehomozygous animals, while surprising, is not necessar-
ily in contradiction with previous studies. It is widely by the first three decades of life. Two genetic mouse
models for hyperphenylalaninemia have been de-accepted that hepatic specific expression is based on
the concerted action of liver enriched and ubiquitous scribed: hph1 (McDonald et al., 1988) and hph5 (McDon-
ald et al., 1990). HNF1-deficient animals accumulatetranscription factors. This idea is well illustrated by the
case of albumin transcriptional control. A short promoter plasma phenylalanine levels that are 9- to 70-fold higher
than littermate controls. The wasting syndrome pre-containing the proximal HNF1-binding site along with a
TATA box is strictly dependent on HNF1. In fact, muta- sented by HNF1 homozygotes could be partially related
to this hyperphenylalaninemia, since the same wastingtions that reduce the binding affinity of HNF1 4-fold
result in a drastic decrease of transcription (more than phenotype and occasionally death can be mimicked in
hph1 and hph5 homozygotes with a phenylalanine over-50-fold). However, similar mutations in a longer pro-
moter (containing four additional cis-acting elements) load. In this respect, HNF1-deficient mice may provide
a good model for PKU. However, clinical studies onhave no effect on transcription. Only mutations that re-
duce the affinity by more than 100-fold can reduce the these animals would be complicated by the presence
of the associated renal and hepatic dysfunction.transcriptional activity to 30% (Tronche et al., 1989).
These data are in agreement with the reduction of albu- Another striking trait of the HNF1-deficient mice was
the dramatic liver enlargement. This is caused by anmin transcription rate we have observed in homozy-
gotes. In addition, up-regulation of vHNF1 may have a increased proliferation of hepatocytes. Hepatomegaly
developed after birth and is probably not correlated withcompensatory effect. The residual hepatic vHNF1 DNA-
binding activity in homozygotes is 10%±15% of the the PKU syndrome, since it was not observed either in
the hph1 or hph5 homozygous mice nor in the humanHNF1 activity present in wild type. This level might com-
pensate in part for the lack of HNF1 for most of the PKU syndrome. This hepatic hyperproliferation may re-
sult from an attempt to compensate for other defectiveHNF1 target genes. We have found that HNF1 deficiency
had a more drastic effect on the transcription of the hepatic functions. In addition, increased transaminase,
PAH gene. In mouse liver, PAH is normally expressed a cholesterol, and bilirubin levels suggest that homozy-
few days before birth, but it was not switched on in the gotes suffer from hepatocellular damage. Further stud-
mutant mice. In addition, kidney proximal tubular cells ies are required to elucidate the mechanisms of the
possibly lacked an essential element needed for the hepatic dysfunction in these mice.
reabsorption of primary urine components such as glu-
cose and amino acids. HNF1 and vHNF1 are each ex-
Kidney Phenotypepressed in the same cell type in proximal tubules. The
Homozygous mice present a renal Fanconi syndromepersistent and abundant vHNF1 expression in this cell
(Lignac±de Toni±DebreÂ±Fanconi syndrome) character-type in homozygotes apparently cannot compensate for
ized by polyuria, glucosuria, phosphaturia, and general-the HNF1 deficiency. Hence the function of these two
ized aminoaciduria. This syndrome results from multipleproteins, at least in kidney, should not entirely overlap.
transport dysfunctions mainly restricted to the renalSince HNF1 is present as a heterodimer in association
proximal tubules. One of the primary functions of thesewith vHNF1 in kidney nuclear extracts, we cannot rule
tubules is the reabsorption of small plasma moleculesout that vHNF1±HNF1 heterodimers fulfill an essential
function. that are freely filtered by the glomeruli. Glucose and
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free amino acids represent the bulk of the reabsorbed surprising that most of the animals died around the
weaning period. This is a critical transition time from achemical species. These reabsorption processes are
generally based on secondary active transport mediated condition in which the water intake is guaranteed by
maternal milk to a situation in which the animals haveby specific carriers. Most, if not all, of these transports
rely on the Na1 electrochemical gradient across the api- to start eating solid food. Weaning homozygotes must
drink large amounts of water to compensate for thecal brush border membrane of proximal tubular cells.
This gradient is maintained by the basolateral Na1, K1 strong polyuria and the increased dietary osmotic load
linked to the regimen switch. Similarly, in human infantsATPase.
Inherited Fanconi syndrome can be associated with affected by diabetes insipidus, a disorder that impairs
the renal primary urine concentration, large volumes ofa number of primary Mendelian diseases including the
following: cystinosis, hereditary fructose intolerance, water are lost in the urine. In these patients, a major
growth arrest occurs at weaning underlying the criticalgalactosemia, tyrosinemia type I, Wilson's disease, vita-
min D±dependent rickets, glycogen storage disease importance of this transition when water needs are
strongly augmented (Royer et al., 1983).type 1, and oculocerebrorenal (Lowe) syndrome. In
some cases, inherited Fanconi syndrome is idiopathic Aminoaciduria is another hallmark of HNF1 deficiency
syndrome with arginine one of the amino acids that is(absence of any defined Mendelian disease). The basic
cellular defect underlying the Fanconi syndrome is un- massively lost in HNF12/2 animals. This defect leads to
a strong depletion of this amino acid. Arginine is essen-known. Four mechanisms have been hypothesized
(Brenner and Rector, 1991): a defective entry of mole- tial for the urea cycle, especially in rodents in which the
endogenous arginine synthesis is less efficient than incules at the apical membrane due to a general dysfunc-
tion of the cotransporters; a defective entry coupled the other mammals. Partial impairment of the urea cycle
might explain the mild hyperammonemia and the urinarywith an increased back leak; an impaired basolateral
membrane transport; impaired mitochondrial ATP pro- orotic acid found in HNF1-deficient animals.
Another striking phenomenon is the apparent reduc-duction with subsequent reduction in the activity of the
basolateral membrane Na1, K1 ATPase. tion of the renal glomerular filtration rate in the mutants.
We hypothesize that this reduction of the filtered bloodThe molecularmechanism that underlies Fanconi syn-
drome in HNF1-deficient animals is still unknown. The volume per unit time is a compensatory response to
the defective reabsorption in the proximal tubules. Thereduced number of Na1/glucose cotransporter mole-
cules detected by phlorizin binding to brush border same phenomenon occurs in patients affected by Fan-
coni syndrome who may develop chronic renal failuremembranes could result from reduced stability or im-
proper membrane insertion of the cotransporter com- (Brenner and Rector, 1991). To our surprise, this reduc-
tion of renal function in homozygous mice did not con-plex. One possibility is that HNF1 directly regulates a
factor necessary for proper cotransporter localization sistently result in augmented plasma creatinine levels,
which normally accompany renal failure. However, en-or function. Alternatively, reduced Na1/glucose cotrans-
porter activity may be due to improper general polariza- dogenous creatinine production is known to be propor-
tional to the total body muscular mass, a mass thattion of the tubular cells. Electron microscopy imaging
did not reveal significant alteration of the brush border is reduced in HNF12/2 animals. In addition, arginine is
among the metabolic precursors of creatine, and in mu-membrane in proximal tubular cells of mutant homozy-
gotes (data not shown). However, more subtle molecular tant homozygotes, this amino acid is much lower than
in the controls.defects present in the brush border membrane cannot
be ruled out. The combination of hyperphenylalaninemia and idio-
pathic Fanconi syndrome is atypical in human. No cases
of association between these two diseases has been
Clinical Consequences of HNF1 reported. One possible explanation for this discrepancy
Deficiency Syndrome is a possible embryonic lethality of the human HNF12/2
HNF1-deficient animals suffered from impaired growth syndrome. However, it should be mentioned that human
and a wasting syndrome. These traits could be ex- and mouse PAH promoters differ extensively in their
plained by massive urinary glucose loss, which in turn sequences (Wang et al., 1994; D. Faust and M. Weiss,
upsets the energy balance. This glucose loss amounted personal communication). It is possible that the mouse
in some cases to more than 1 g/day. The daily food and human PAH genes are under the control of different
intake of a homozygous mouse was on average 1.5 g chromosomal regions with different transcriptional reg-
consisting of 10% lipid, 20% protein, and 60% carbo- ulatory signals. This idea would suggest that the putative
hydrate. Homozygotes may attempt to compensate human HNF1 deficiency syndromemight not necessarily
for their glucose loss with constitutively activated present the PKU trait.
gluconeogenesis together with polyphagic behavior. In this work, we have shown that HNF1 disruption
This defective glucose/energy balance forces HNF12/2 does not profoundly affect embryonic development.
animals to catabolize their own proteins for gluconeo- This is in contrast with the embryonic lethal phenotypes
genic purposes, giving rise to the wasting syndrome. resulting from the disruption of two other liver-enriched
Thus, the elevated hydroxyproline plasma levels proba- factors HNF3b (Ang and Rossant, 1994; Weinstein et al.,
bly derived fromthe catabolism of bones and connective 1994) and HNF4 (Chen et al., 1994). The onset of HNF1
tissues. expression is relatively late compared with either HNF3b
The severe glucosuria also has a drastic effect on or HNF4. In addition, HNF1 expression is specifically
restricted to developing organs and does not involvethe water balance inducing osmotic diuresis. It is not
Liver and Kidney Dysfunction in HNF1 Mutant Mice
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pPH plasmid (D. Faust and M. Weiss, personal communication);pivotal structures such as the primitive streak, Hensen's
aldolase B was a 1400 bp PstI fragment (Besmond et al., 1983);node, and the notochord where HNF3b is transcribed,
Protein C was detected with a human cDNA fragment.or the visceral endoderm where HNF4 is active. These
Nuclei from liver and kidney were prepared as described (Lichts-
results, taken together with our findings, show that liver teiner et al., 1987). Run-on assays were performed essentially as
specific transcription involves two functionally different described (Linial et al., 1985). Filters were exposed to phospho-
coated screens for 12 hr. Screens were scanned with a phosphoi-classes of transcription factors. One class of genes is
mager instrument and the signals analyzed using ImageQuant soft-involved in early embryonic development (e.g., HNF3b
ware (Molecular Dynamics).and HNF4), while the second class (including HNF1 and
DBP) is expressed relatively late and only during hepatic
Immunoblot Analysis
determination and differentiation. This second class Equal amounts of nuclear protein extracts, after denaturation for 5
might best be described as maintenance genes rather min at 1008C in loading buffer, were separated on 7% acrylamide
than developmental genes. SDS gels under standard conditions, electrotransferred to nitrocel-
lulose, and washed in PBS plus 0.1% Tween (PBST). Nitrocellulose
filters were incubated with 4% milk powder in PBST for 30 min,Experimental Procedures
washed twice in PBST, and then treated with a primary antibody
for 1 hr at room temperature. After several washes in PBST, filtersTargeting Vectors and Generation of Chimaeric Mice
were incubated with a horseradish peroxidase±conjugated second-HNF1 genomic clones were isolated from a genomic cosmid library
ary antibody for 1 hr in PBST, washed several times in PBST, andprepared from 129/Sv mouse DNA. A 3.5 kb NcoI±BamHI fragment
eventually developed with ECL detection technique. Mouse mono-containing the LacZ cassette was isolated from a modified pCHNLS
clonal antibody anti-vHNF1 3±12 was produced by FrancËois Train-plasmid provided by P. Brulet. This cassette was cloned into a
chart and Tanguy Chouard. Rabbit polyclonal antibodies againstmodified Blue Scribe (Promega) plasmid in which the polylinker in
HNF1 284 and 183 were produced by Tanguy Chouard.the NdeI±HindIII fragment was replaced by a new one containing
the following sites: NdeI, SalI, NcoI, BamHI, SalI, and HindIII.
Nuclear Extracts and Electromobility Shift AssaysThen the SalI±SalI fragment containing the promoter and the LacZ
Nuclear extracts were prepared as described by Cereghini et al.cassette fused at the level of the ATG start codon (NcoI site) was
(1987) or as described by Lavery and Schibler (1993). Binding assayscloned into the XhoI site of pPNT (Tybulewicz et al., 1991) with the
were performed as described (Cereghini et al., 1987). The HNF1same transcriptional orientation as the neomycin cassette of pPNT.
probes consisted of double-stranded 30 bp oligonucleotides cen-Subsequently, we cloned in the KpnI site different portions of the
tered on the elements of the rat albumin, a1-antitrypsin, b-fibrino-59 part of the first intron: a HindIII fragment of 8.1 kb located 68 nt
gen, and liver pyruvate kinase promoters. For NFY, we used a 30downstream of the first exon 39 boundary was cloned into Blue
bp oligonucleotide corresponding to the CAAT box of the ratalbuminScribe plasmid in the two possible orientations. A KpnI digestion
promoter. For HNF4, we used the HNF4-binding site located in thecould provide, according to the insert orientation, both the proximal
HNF1 promoter. Oligonucleotides were labeled with polynucleotideand distal part of the intron of 4.0 kb that were cloned into the KpnI
kinase in the presence of [g-32P]ATP. Anti-vHNF1 (GST±HNF1b) anti-site of the previously produced plasmid with the same orientation
bodies used in electromobility shift assays were provided by G. R.as the left arm. This cloning strategy gave rise, respectively, to pH2
Crabtree.and pH1 vectors. Both the homologous recombination vectors had
3.1 and 4.0 kb of homology with the HNF1 locus. Plasmids were
Renal Brush Border Membrane Isolation andlinearized with NotI before electroporation.
Phlorizin Binding AssayES cells were cultured essentially as described (Robertson, 1987)
Brush border from renal proximal tubules were isolated essentiallywith the addition of leukemia inhibitory factor 103 U/ml. ES cell
as described (Malathi et al., 1979) with the exception that wholeelectroporation and isolation of neomycin resistant clones were per-
kidneys instead of isolated cortices were used. Binding assays wereformed as described (Colucci et al., 1994). BamHI-digested DNA
performed as described (Koepsell et al., 1990). The results werefrom ES drug resistant clones was analyzed by Southern blot using
corrected for nonspecific binding by subtracting [3H]phlorizin bind-as probe an AccI fragment located immediately upstream of the
ing, which was measured in presence of 5 mM nonlabeled phlorizin.homology region with the left arm of the homologous recombination
vectors. ES cell clones injection and implantation were done as
Mouse Tail DNA Analysispreviously described (Bradley, 1987).
DNA from mouse tails was extracted and analyzed by PCR using a
mixture of three different primers. The primers were chosen in theRNA Analysis and Nuclear Run-On Assays
HNF1 promoter (plus strand) (GGCCGCTGGGGCCAGGGTTG), in theTotal RNA was isolated according to Chomczynski and Sacchi
first HNF1 exon (minus strand) (CCAGGGGACCCTCTCCAACC), and(1987). Poly(A)1 mRNAs were isolated with oligo(dT) cellulose chro-
in the b-galactosidase cassette (minus strand) (GGGAAGGGC-matography essentially as described (Sambrook et al., 1989). For
GATCGGTGCGG). Two possible amplification products with differ-Northern blot analysis, 3 mg of poly(A)1 or 15 mg of total RNA were
ent length could be produced according to the mouse genotype.separated in 0.66 M formaldehyde 1% agarose gels and blotted to
The amplified bands corresponding to the wild-type and to theHybond N (Amersham) nylon membranes. Prehybridization, hybrid-
mutated allele are 300 bp and 400 bp, respectively.ization,and washing were performedas recommended by the manu-
facturer. Probes were labeled with random priming. HNF1 probe
consisted of the full-length cDNA corresponding to the 1627 bp X-Gal Staining and Histological Analysis
To detect b-galactosidase activities in toto, mouse organs wereHindIII±StuI fragment from RSV±HNF1 plasmid (Chouard et al.,
1990); vHNF1 probe was a 738 bp AvaI±AccI fragment derived from dissected, fixed in PBS containing 4% paraformaldehyde for 20 min,
and then washed three times in PBS. X-Gal staining was performedRSV±vHNF1 (Rey Campos et al., 1991); HNF4 probe was a 3 kb
BamHI insert from pLEN4S (Sladek et al., 1990); DCoH probe was by an incubation at 328C for 3 hr to overnight in a staining solution
containing 2 mM MgCl2, 4 mM K3Fe(CN)6, 4 mM K4Fe(CN)6, and 0.4a EcoRI 325 bp fragment extracted from the DCoH expression vector
(Mendel et al., 1991); albumin probe was a PstI 1100 bp fragment mg/ml 4-chloro-5-bromo-3-indolyl-b-D-galactopyranoside (X-Gal;
BRL Life Technologies). For X-Gal staining of histological thin sec-from pMSA433 plasmid (Sellem et al., 1984); a-fetoprotein probe
was a PstI 700 bp fragment from pMSA433 plasmid (Sellem et al., tions, after fixation and washing organs were soaked in 30% sucrose
overnight at 48C. Next day specimens were frozen and cut with1984); a1-antitrypsin probe was a PstI fragment of 400 bp from
pLIV3 plasmid (Derman et al., 1981); transferrin probe was a PstI cryotome at 5±20 mm. b-galactosidase activity was revealed with 3
hr to overnight incubations at 328C in the same type of X-Gal solution1500 bp fragment from pTF plasmid (Derman et al., 1981); liver-type
pyruvate kinase was 1800 bp PstI fragment from PKLG4 plasmid used for in toto staining. After X-Gal staining sections were counter
stained with phloxine B.(Lone et al., 1986); PAH was a 400 bp PstI±HindII fragment from
Cell
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Plasma and Urine Biochemical Analysis Chen, W.S., Manova, K., Weinstein, D.C., Duncan, S.A., Plump, A.S.,
Prezioso, V.R., and Bachvarova, R.F. (1994). Disruption of the HNF-4Blood was obtained by intracardiac puncture from animals under
avertin anaesthesia. Urine was collected with Tecniplast metabolic gene, expressed in visceral endoderm, leads to cell death in embry-
onic ectoderm and impaired gastrulation of mouse embryos. Genescages. Frozen plasma or urine were analyzed on Kodak automated
analyzer. Amino acid levels in serum and urine were determined Dev. 8, 2466±2477.
by ion exchange chromatography with ninhydrin detection using Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
Beckman's system 6300 analyzer. Determination of orotic and dihy- isolation by acid guanidinium thiocyanate-phenol-chloroform extac-
droorotic acids in biological fluids were performed as described tion. Anal. Biochem. 162, 120±129.
(Kesner et al., 1975). Since HNF1-deficient animals did not tolerate
Chouard, T., Blumenfeld, M., Bach, I., Vandekerckhove, J., Cere-starvation, all biochemical analysis were performed on nonfasting
ghini, S., and Yaniv, M. (1990). A distal dimerization domain is essen-animals. Paired t student test was applied to the values obtained
tial for DNA-binding by the atypical HNF1homeodomain. Nucl. Acidsfrom couples of mutant and control animals coming from the same
Res. 18, 5853±5863.litter and sacrificed at the same time.
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